spacer
spacer

PDBsum entry 4u84

Go to PDB code: 
protein ligands links
Isomerase PDB id
4u84

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
145 a.a.
Ligands
15P
Waters ×101
PDB id:
4u84
Name: Isomerase
Title: Human pin1 with s-hydroxyl-cysteine 113
Structure: Peptidyl-prolyl cis-trans isomerase nima-interacting 1. Chain: a. Synonym: peptidyl-prolyl cis-trans isomerase pin1,ppiase pin1, rotamase pin1. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: pin1. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.78Å     R-factor:   0.197     R-free:   0.224
Authors: W.Li,Y.Zhang
Key ref: C.H.Chen et al. (2015). Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease. Neurobiol Dis, 76, 13-23. PubMed id: 25576397 DOI: 10.1016/j.nbd.2014.12.027
Date:
01-Aug-14     Release date:   08-Apr-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q13526  (PIN1_HUMAN) -  Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 from Homo sapiens
Seq:
Struc:
163 a.a.
145 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.5.2.1.8  - peptidylprolyl isomerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: [protein]-peptidylproline (omega=180) = [protein]-peptidylproline (omega=0)
Peptidylproline (omega=180)
= peptidylproline (omega=0)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1016/j.nbd.2014.12.027 Neurobiol Dis 76:13-23 (2015)
PubMed id: 25576397  
 
 
Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease.
C.H.Chen, W.Li, R.Sultana, M.H.You, A.Kondo, K.Shahpasand, B.M.Kim, M.L.Luo, M.Nechama, Y.M.Lin, Y.Yao, T.H.Lee, X.Z.Zhou, A.M.Swomley, D.Allan Butterfield, Y.Zhang, K.P.Lu.
 
  ABSTRACT  
 
The unique proline isomerase Pin1 is pivotal for protecting against age-dependent neurodegeneration in Alzheimer's disease (AD), with its inhibition providing a molecular link between tangle and plaque pathologies. Pin1 is oxidatively modified in human AD brains, but little is known about its regulatory mechanisms and pathological significance of such Pin1 modification. In this paper, our determination of crystal structures of oxidized Pin1 reveals a series of Pin1 oxidative modifications on Cys113 in a sequential fashion. Cys113 oxidization is further confirmed by generating antibodies specifically recognizing oxidized Cys113 of Pin1. Furthermore, Pin1 oxidation on Cys113 inactivates its catalytic activity in vitro, and Ala point substitution of Cys113 inactivates the ability of Pin1 to isomerize tau as well as to promote protein turnover of tau and APP. Moreover, redox regulation affects Pin1 subcellular localization and Pin1-mediated neuronal survival in response to hypoxia treatment. Importantly, Cys113-oxidized Pin1 is significantly increased in human AD brain comparing to age-matched controls. These results not only identify a novel Pin1 oxidation site to be the critical catalytic residue Cys113, but also provide a novel oxidative regulation mechanism for inhibiting Pin1 activity in AD. These results suggest that preventing Pin1 oxidization might help to reduce the risk of AD.
 

 

spacer

spacer